---All---
  • ---All---
  • Accession
  • Catalog #

AGFG1 Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP16184a 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP16184a-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

AGFG1 Antibody (N-term) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP52594
Other AccessionQ4KLH5, Q8K2K6, Q2TA45, NP_004495.2, NP_001128661.1, NP_001128660.1
ReactivityHuman
PredictedBovine, Mouse, Rat
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW58260 Da

AGFG1 Antibody (N-term) - Additional info

Gene ID 3267
Other Names
AGFG1; HRB; RAB; RIP; Arf-GAP domain and FG repeat-containing protein 1; HIV-1 Rev-binding protein; Nucleoporin-like protein RIP; Rev-interacting protein; Rev/Rex activation domain-binding protein
Target/Specificity
This AGFG1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human AGFG1.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
AGFG1 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.

AGFG1 Antibody (N-term) - Protein Information

Name AGFG1
Synonyms HRB, RAB, RIP
Function
Required for vesicle docking or fusion during acrosome biogenesis (By similarity). May play a role in RNA trafficking or localization. In case of infection by HIV-1, acts as a cofactor for viral Rev and promotes movement of Rev-responsive element- containing RNAs from the nuclear periphery to the cytoplasm. This step is essential for HIV-1 replication
Cellular Location
Nucleus. Cytoplasmic vesicle.
Tissue Location
Ubiquitously expressed.

AGFG1 Antibody (N-term) - Related products

AP16184a: AGFG1 Antibody (N-term)

DC06111: Human AGFG1 cDNA Clone

LY12755a: AGFG1 Over-expression Lysate

AGFG1 Antibody (N-term) - Application data

  • AGFG1 Antibody (N-term) (Cat. #AP16184a) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the AGFG1 antibody detected the AGFG1 protein (arrow).

AGFG1 Antibody (N-term) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The protein encoded by this gene is related to nucleoporins, a class of proteins that mediate nucleocytoplasmic transport. The encoded protein binds the activation domain of the human immunodeficiency virus Rev protein when Rev is assembled onto its RNA target, and is required for the nuclear export of Rev-directed RNAs. Multiple transcript variants encoding different isoforms have been found for this gene.

REFERENCES

Bowes, J.D., et al. Pharmacogenet. Genomics 19(4):319-323(2009) Chaineau, M., et al. J. Biol. Chem. 283(49):34365-34373(2008) Pryor, P.R., et al. Cell 134(5):817-827(2008) Sugiyama, N., et al. Mol. Cell Proteomics 6(6):1103-1109(2007) Olsen, J.V., et al. Cell 127(3):635-648(2006)